Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1, reflecting a minor site-version update.SummaryDifference0.1%

- Check15 days agoChange DetectedThis snapshot shows the study record history with multiple version entries, but no additions or deletions are recorded in this dataset.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded a new revision entry v3.7.0 to the history, indicating a page/system update. The prior revision v3.6.6 is removed from the deletions, updating the record of changes shown on the history page.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, indicating an updated version of the record, and the previous revision v3.6.5 was removed from the visible list.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page’s revision label in the footer was updated from v3.6.4 to v3.6.5, signaling a minor platform update rather than a change to the study data list. This update affects how the page presents its version, not the content of the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This appears to be a metadata update rather than a user-facing content change.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.